BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study

Reuters · Oct 7, 2020 19:43

Oct 7 (Reuters) - Mateon Therapeutics Inc MATN.PK :

* MATEON THERAPEUTICS INC - ANNOUNCED FIRST PATIENT ENROLLED THIS WEEK IN ITS PHASE IV STUDY ARTI-19

* MATEON THERAPEUTICS INC - TOP-LINE DATA FROM ARTI-19 IS EXPECTED BY END OF 4Q20

Source text for Eikon: Further company coverage:

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study

Risk Disclaimer